Reaction

Cardiac Ablation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,747 reports · 38 co-occurring drugs

As of the last recalculation, Cardiac Ablation appears in 1,747 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is DOFETILIDE (PRR 74.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dofetilide6374.174.5
Sotalol Hydrochloride4835.335.4
Epoprostenol3633.433.5
Dronedarone2732.032.1
Bosentan9022.422.4
Dabigatran Etexilate Mesylate11520.120.2
Selexipag3918.418.4
Dabigatran Etexilate10817.617.6
Apixaban7914.714.7
Tafamidis1414.314.3
Sildenafil Powder,3913.313.3
Macitentan7413.313.3
Amiodarone Hydrochloride1212.812.9
Icosapent Ethyl912.712.7
Riociguat3011.111.1
Rivaroxaban17210.810.8
Ranolazine910.310.3
Sildenafil479.99.9
Agalsidase Beta79.19.1
0Xygen358.68.6
Oxygen358.68.6
Metolazone88.58.5
Sildenafil Citrate858.38.3
Tolvaptan108.28.2
Risankizumab-Rzaa548.18.1
Tadalafil658.08.0
Dolutegravir Sodium56.66.6
Relugolix136.66.6
Nintedanib176.56.5
Ambrisentan636.26.2
Ibrutinib406.06.0
Treprostinil565.55.5
Umeclidinium Bromide And Vilanterol Trifenatate75.05.0
Oral Semaglutide264.34.3
Guselkumab82.72.7
Droxidopa42.22.2
Pirfenidone61.81.8
Evolocumab201.51.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.